Friday, November 01, 2013

Diabetes Awareness Month 2013- Just Who is On The Guideline Committees?

As you all have probably noticed, my blog was offline for about ten months. I have removed a large number of posts due to privacy concerns but the rest of the blog is back. It may look a little disjointed if you read through the archives.

Today kicks off November, aka Diabetes Awareness Month. Many folks for this month get "facts" each day from diabetes organizations that are aimed at the general public about how big and scary and awful diabetes is without much real data or explanation. Sort of in reaction, I started posting a fact per day that is aimed at people who do have some familiarity with diabetes and that I do my very best to make sure really is backed up by some data.

I have taken down many of the posts that said much about me so this much you may want to know: I am a young adult diagnosed with type 1 diabetes at the age of 17. I have a small amount of medical training, but almost all of what I will post here about diabetes is self taught. I currently use a jet injector and inject Novolin R and an insulin pen for injecting Lantus. I also use a Dexcom G4. I live in the United States and I have private medical insurance.

So, welcome back if you're an old reader and also welcome if you're a new reader.

Today's fact is not directly about diabetes, but about guidelines for treatment. In the United States, you have probably seen A1c or other diabetes management recommendations from the American Diabetes Association and/or the American Association of Clinical Endocrinologists. 
You should know that 19 out of 21 authors of the AACE's 2012 diabetes guidelines had received payments from one or more company making diabetes drugs, and that 15 out of 16 of the authors of the ADA's 2012 diabetes guidelines had received money from one or more companies making diabetes drugs.

Of the 19 authors of the 2013 Guidelines, 10 report monies received or affiliations from the past year, but 15 have received money from a pharmaceutical company at some point, and that does not include two working for the ADA.

Nathaniel Clark received two thousand six hundred seventy five dollars for one speaking engagement for Eli Lilly in 2011.
Cyrus Desouza reports getting monies from grants from Novo Nordisk.
Martha Funnell has recieved monies for speaking and consulting for Eli Lilly and Merck in 2009, 2010, and 2011 to the tune of over $25,000 on only five days.
Allison Goldfine reports monies from public grant research funds as well as numerous pharmaceutical companies.
Richard Grant works for Kaiser Permanante and I'm not sure if he's the same Richard Grant who got $1,200 from J&J for a speaking engagement. He has also received monies from governmental grants.
James Lenhard has made more than $28,000 for speaking for AstraZeneca and Merck, and he also has received governmental monies for research.
Jennifer Marks reports monies for research from Eli Lilly as well as others.
Anthony McCall has gotten monies from Pfizer, Aventis, and Eli Lilly and the government.
Janis McWilliams was paid a little over two grand from Eli Lilly for "other".
Harsha Rao has received a little under a thousand dollars for "meals" from Pfizer.
Andrew Rhinehat reports only his research grants, but additionally has received almost 30 grand from Eli Lilly and Forest, none of it for research.
Henry Rodriguez received more than $50,000 from Eli Lilly in a two year period for non-research items, and he reports also money from the government, trusts, Novartis, Squibb, and Merck.
Debra Simmons reports research monies from Novo Nordisk.
Patricia Urbanski received three thousand dollars from Eli Lilly for consulting.
Carol Wysham, chair, received more than a quarter million dollars from Eli Lilly, although she reports only research money from charitable and governmental grants.

No comments: